SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-063499
Filing Date
2022-05-20
Accepted
2022-05-20 17:25:51
Documents
11
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2216216d1_6k.htm 6-K 14161
2 EXHIBIT 99.1 tm2216216d1_ex99-1.htm EX-99.1 791048
3 EXHIBIT 99.2 tm2216216d1_ex99-2.htm EX-99.2 9465
4 EXHIBIT 99.3 tm2216216d1_ex99-3.htm EX-99.3 4503
5 GRAPHIC tmb-20220517xex99d2g001.jpg GRAPHIC 160109
6 GRAPHIC tmb-20220517xex99d2g002.jpg GRAPHIC 189620
7 GRAPHIC tmb-20220517xex99d3g001.jpg GRAPHIC 126455
8 GRAPHIC tmb-20220517xex99d3g002.jpg GRAPHIC 114326
9 GRAPHIC tm2216216d1_ex99-1img002.jpg GRAPHIC 12990
10 GRAPHIC tm2216216d1_ex99-1img001.jpg GRAPHIC 34664
11 GRAPHIC tm2216216d1_ex99-1img003.jpg GRAPHIC 16677
  Complete submission text file 0001104659-22-063499.txt   1723050
Mailing Address 1744 WILLIAM STREET, SUITE 200 MONTREAL A8 H3J 1R4
Business Address 1744 WILLIAM STREET, SUITE 200 MONTREAL A8 H3J 1R4 514-937-0002 EXT 227
PyroGenesis Canada Inc. (Filer) CIK: 0001743344 (see all company filings)

IRS No.: 980627529 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39989 | Film No.: 22948873
SIC: 2834 Pharmaceutical Preparations